Bernd Schmidt
Technik-/Wissenschafts-/F&E-Leiter bei SENSORION
Aktive Positionen von Bernd Schmidt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SENSORION | Technik-/Wissenschafts-/F&E-Leiter | 11.12.2023 | - |
Karriereverlauf von Bernd Schmidt
Ehemalige bekannte Positionen von Bernd Schmidt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Ausbildung von Bernd Schmidt
| Friedrich-Alexander University of Erlangen-Nuremberg | Graduate Degree |
Statistik
International
| Deutschland | 2 |
| Vereinigtes Königreich | 2 |
| Frankreich | 2 |
Operativ
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SENSORION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Bernd Schmidt
- Erfahrung
